Senior Director, FasterCures, Milken Institute Health
Kristin Schneeman is senior director on the FasterCures team at the Milken Institute, where she oversees most policy and programmatic activities, focused on improving the research and development environment, engaging patients in research and health, and accelerating innovation.
Real-world insights (RWI) are transforming clinical research decision-making by integrating health care, consumer, behavioral, and digital data to provide a more complete and continuous view of patients' lives. By moving beyond episodic encounters, RWI offers more comprehensive visibility into the medical, behavioral, social, and economic factors that affect patient participation in research and the scientific and operational success of trials.
The value proposition of RWI extends beyond operational efficiency in trials to encompass opportunities to use data to enhance patient engagement, accelerate therapeutic access, and advance personalized approaches to treatment.
In this report, FasterCures explores the current uses and future promise of RWI for the clinical research enterprise and the challenges that must be addressed to realize its full potential—including technical, operational, and ethical considerations, as well as the regulatory guardrails needed to support its responsible use.
The 2025 Milken Institute Future of Health Summit centered on the theme In Service of Better Health. The event featured more than 200 speakers from diverse sectors and industries, spanning nearly 60 sessions that covered a broad range of...
FasterCures’ Access Point: Trends in Clinical Trials Transformation is a quarterly horizon scan examining how emerging trends, organizations, and initiatives are transforming clinical trial access and efficiency. Each issue highlights...
FasterCures’ Access Point: Trends in Clinical Trials Transformation is a quarterly horizon scan examining how emerging trends, organizations, and initiatives are transforming clinical trial access and...
The United States biomedical research and innovation enterprise has long been a source of global leadership, scientific breakthroughs, and lifesaving treatments. Decades of investments in research and development have positioned the US as...
The United States biomedical research and innovation enterprise has long been a source of global leadership, scientific breakthroughs, and lifesaving treatments.
FasterCures is launching Access Point: Trends in Trial Transformation, a quarterly horizon scan examining how emerging trends, organizations, and initiatives are transforming clinical trial access and efficiency.
The ATF-LOMAS is now accepting applications for awards of up to $100,000 per year for two-year research projects led by early career investigators who seek to increase the foundational understanding of sarcoidosis through projects focused...
The 2024 Milken Institute Future of Health Summit centered on the theme Partnering for Better Health. The two-day event featured more than 200 speakers across diverse industries and sectors in more than 50 sessions about innovative...
When I was first told cancer vaccines were in clinical trials, and I had never heard of them before, I was shocked. I was a survivor. I was a medical journalist. I was steeped in the world of cancer, and I had never heard of such a thing...
Thanks to groundbreaking advances in science and technology, we are moving closer to eliminating cancer as a cause of death and turning science into medicine at a pace we’ve never seen before. And yet, the burden of cancer continues to grow...